libtayohcp.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
#updated 12/8/2021 User-agent:* Sitemap: https://www.libtayohcp.com/sitemap.xml | ||
Meta Tags
| Title | LIBTAYO® (cemiplimab-rwlc): Official Healthcare Professional |
| Description | LIBTAYO has been proven in pivotal trials in the following tumor Healthcare professionals can find information about approved indications for LIBTAYO (cemiplimab-rwlc) along with treatment guidelines and resources. Review Serious Adverse Reactions & Full |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 212.121.182.99 |
| Location | France |
Related Websites
| Site | Rank |
More to Explore
libtayohcp.com Valuation
|
US$22,026,632
Last updated: 2022-06-17 21:17:51
libtayohcp.com has Semrush global rank of 480,523. libtayohcp.com has an estimated worth of US$ 22,026,632, based on its estimated Ads revenue. libtayohcp.com receives approximately 2,541,535 unique visitors each day. Its web server is located in France, with IP address 212.121.182.99. According to SiteAdvisor, libtayohcp.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$22,026,632 |
| Daily Ads Revenue | US$20,333 |
| Monthly Ads Revenue | US$609,969 |
| Yearly Ads Revenue | US$7,319,620 |
| Daily Unique Visitors | 169,436 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| libtayohcp.com. | A | 7199 | IP: 212.121.182.99 |
| libtayohcp.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
| libtayohcp.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
| libtayohcp.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
| libtayohcp.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
| libtayohcp.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
| libtayohcp.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
| libtayohcp.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
| libtayohcp.com. | TXT | 86400 | TXT Record: v=spf1 -all |
HtmlToTextCheckTime:2022-06-17 21:17:51
| For US Healthcare Professionals Only Important Safety Information Important Safety Information Prescribing Information Patients and Caregivers Site Contact a rep LIBTAYO on Facebook For Healthcare Professionals LIBTAYO Product Site Select Cancer Type Advanced NSCLC Locally Advanced BCC Advanced CSCC LIBTAYO has been proven in pivotal trials in the following tumor types 1,2 : NOW APPROVED --> As a first-line treatment option in advanced NSCLC Studied in one of the largest clinical trials of patients with advanced NSCLC expressing PD-L1 ≥50% 1,3 LIBTAYO is indicated for the first-line treatment of patients with non–small cell lung cancer (NSCLC) whose tumors have high PD-L1 expression [tumor proportion score (TPS) ≥50%] as determined by an FDA-approved test, with no EGFR, ALK, or ROS1 aberrations, and is 1 : Locally advanced where patients are not candidates for surgical resection or definitive chemoradiation or 1 Metastatic 1 Learn more > NOW APPROVED --> Locally Advanced BCC |
HTTP Headers
HTTP/1.1 302 Found Date: Fri, 22 Oct 2021 08:23:56 GMT Server: Apache/2.4.48 (codeit) Location: https://www.libtayohcp.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/2 200 content-type: text/html; charset=utf-8 content-length: 89547 vary: Accept-Encoding date: Fri, 22 Oct 2021 08:23:56 GMT set-cookie: AWSALB=jiuagYRUrd2cgWOo6TBcOPLTtiDdIMrbtnaRgLhxtmo7arobaxOsG/H/Zypi433m+t6qVHmE2aqWeN3N8HOm8DlgXeX8rOMo/JGz4o9XyLkRwQNtp19X0QD1G6R3; Expires=Fri, 29 Oct 2021 08:23:56 GMT; Path=/ set-cookie: AWSALBCORS=jiuagYRUrd2cgWOo6TBcOPLTtiDdIMrbtnaRgLhxtmo7arobaxOsG/H/Zypi433m+t6qVHmE2aqWeN3N8HOm8DlgXeX8rOMo/JGz4o9XyLkRwQNtp19X0QD1G6R3; Expires=Fri, 29 Oct 2021 08:23:56 GMT; Path=/; SameSite=None; Secure cache-control: private server: Microsoft-IIS/10.0 x-aspnetmvc-version: 5.2 x-aspnet-version: 4.0.30319 x-powered-by: ASP.NET x-cache: Miss from cloudfront via: 1.1 742fd95a67b644c7cd7f9d39f6e0f880.cloudfront.net (CloudFront) x-amz-cf-pop: ORD53-C1 x-amz-cf-id: 8Ba7yISQowiFFfm91YSjCQtbso_dJyIyHgMOStsTmVma-XZ-hNMnKw== |
libtayohcp.com Whois Information
Domain Name: LIBTAYOHCP.COM Registry Domain ID: 2159910439_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-08-04T09:04:40Z Creation Date: 2017-09-05T15:41:59Z Registry Expiry Date: 2023-09-05T15:41:59Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-10T23:59:54Z <<< |